Skip to main content

Brookstone Capital Management

Position in GILD — Gilead Sciences, Inc.

CIK 1599584 WHEATON, IL

Position in GILD

as of Jun 30, 2026 · filed Jul 15, 2026
Position Value
$18,292,010
+$3,844,638 QoQ
Shares Held
144,784
+39.7% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#337
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Brookstone Capital Management holds $235,547,820 across 12 Drug Manufacturers - General names. GILD ranks #5 (7.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 GILD
Gilead Sciences, Inc.
This page
144,784 $18,292,010

All Filings in GILD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,292,010 144,784
2026-03-31 $14,447,372 103,662
2025-12-31 $14,160,513 115,370
2025-09-30 $13,392,039 120,649
2025-06-30 $13,668,940 123,288
2025-03-31 $13,383,252 119,440
2024-12-31 $13,620,141 147,452
2024-09-30 $12,312,071 146,852
2024-06-30 $10,007,454 145,860
2024-03-31 $9,321,648 127,258
2023-12-31 $1,211,342 14,953
2023-09-30 $1,090,152 14,547
2023-06-30 $1,014,009 13,157
2023-03-31 $1,039,780 12,532
2022-12-31 $1,283,199 14,947
2022-09-30 $10,435,480 169,160
2022-06-30 $9,890,527 160,015
2022-03-31 $6,220,610 104,636
2021-12-31 $5,500,570 75,755
2021-09-30 $5,322,150 76,194
2021-06-30 $4,368,065 63,434
2021-03-31 $3,290,701 50,916
2020-12-31 $3,022,237 51,875
2020-09-30 $2,843,550 45,000
2020-06-30 $2,422,532 31,486
2020-03-31 $2,925,882 39,137